Skip to main content
SpringerLink
Log in

Methotrexate and interstitial lung disease. Is there a real causative factor?

  • Correspondence
  • Published:
Rheumatology International Aims and scope Submit manuscript

The Original Article was published on 29 January 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dawson JK, Quah E, Earnshaw B, Amoasii C, Mudawi T, Spencer LG (2021) Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review. Rheumatol Int 41:1055–1064. https://doi.org/10.1007/s00296-020-04773-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Drosos AA, Pelechas E, Voulgari PV (2020) Treatment strategies are more important than drugs in the management of rheumatoid arthritis. Clin Rheumatol 39:1363–1368. https://doi.org/10.1007/s10067-020-05001-x

    Article  PubMed  Google Scholar 

  3. Turesson C, O’Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2003) Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62:722–727. https://doi.org/10.1136/ard.62.8.722

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wilsher M, Voight L, Milne D, The M, Good N, Kolbe J et al (2012) Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med 106:1441–1446. https://doi.org/10.1016/j.rmed.2012.06.020

    Article  PubMed  Google Scholar 

  5. Perez T, Remy-Jardin M, Cortet B (1998) Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 157:1658–1665. https://doi.org/10.1164/ajrccm.157.5.9710018

    Article  CAS  PubMed  Google Scholar 

  6. Metafratzi ZM, Georgiadis AN, Ioannidou CV, Alamanos Y, Vassiliou MP, Zikou AK et al (2007) Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 36:338–344. https://doi.org/10.1080/03009740701393957

    Article  CAS  PubMed  Google Scholar 

  7. Georgiadis AN, Metafratzi ZM, Drosos AA (2009) Pulmonary abnormalities in patients with early and longstanding rheumatoid arthritis. J Rheumatol 36:444–445. https://doi.org/10.3899/jrheum.080882

    Article  PubMed  Google Scholar 

  8. Mori S, Cho I, Koga Y, Sugimoto M (2008) Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513–1521

    PubMed  Google Scholar 

  9. Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF et al (2012) Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 64:1756–1761. https://doi.org/10.1002/art.34344

    Article  CAS  PubMed  Google Scholar 

  10. Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL (2017) Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol 69:542–549. https://doi.org/10.1002/art.39971

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece

    E. Pelechas, A. N. Georgiadis, P. V. Voulgari & A. A. Drosos

Authors
  1. E. Pelechas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. N. Georgiadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. V. Voulgari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. A. Drosos
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed equally and approved the final version of the Letter.

Corresponding author

Correspondence to A. A. Drosos.

Ethics declarations

Conflict of interest

None by all authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pelechas, E., Georgiadis, A.N., Voulgari, P.V. et al. Methotrexate and interstitial lung disease. Is there a real causative factor?. Rheumatol Int 41, 2045–2046 (2021). https://doi.org/10.1007/s00296-021-04901-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04901-8

Search

Navigation